Select Page
Amgen (NASDAQ: AMGN) receives FDA approval of UPLIZNA

Amgen (NASDAQ: AMGN) receives FDA approval of UPLIZNA

Amgen (NASDAQ: AMGN) receives FDA approval of UPLIZNA Shares of Amgen Inc (NASDAQ: AMGN) climbed 1.4% today after the company announced that the U.S. Food and Drug Administration (FDA) has approved its drug UPLIZNA for the treatment of Immunoglobulin G4-related...